Skip to main content
SpringerLink
Log in

Molecular Biology of HIV-2

  • Living reference work entry
  • First Online:
Book cover Encyclopedia of AIDS

  • 213 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Bennett EM, Lever AM, Allen JF. Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2. J Virol. 2004;78:11303–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bolinger C, Boris-Lawrie K. Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology. 2009;6:8.

    Article  PubMed Central  PubMed  Google Scholar 

  • Boyer PL, Sarafianos SG, Clark PK, Arnold E, Hughes SH. Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance? PLoS Pathog. 2006;2:e10.

    Article  PubMed Central  PubMed  Google Scholar 

  • Briggs JA, Krausslich HG. The molecular architecture of HIV. J Mol Biol. 2011;410:491–500.

    Article  CAS  PubMed  Google Scholar 

  • Camacho RJ. Special aspects of the treatment of HIV-2-infected patients. Intervirology. 2012;55:179–83.

    Article  PubMed  Google Scholar 

  • Choe H, Martin KA, Farzan M, Sodroski J, Gerard NP, Gerard C. Structural interactions between chemokine receptors, gp120 Env and CD4. Semin Immunol. 1998;10:249–57.

    Article  CAS  PubMed  Google Scholar 

  • Fujita M, Otsuka M, Nomaguchi M, Adachi A. Multifaceted activity of HIV Vpr/Vpx proteins: the current view of their virological functions. Rev Med Virol. 2010;20:68–76.

    Article  CAS  PubMed  Google Scholar 

  • Gallo SA, Reeves JD, Garg H, Foley B, Doms RW, Blumenthal R. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion. Retrovirology. 2006;3:90.

    Article  PubMed Central  PubMed  Google Scholar 

  • Garcia-Martinez LF, Mavankal G, Peters P, Wu-Baer F, Gaynor RB. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2. J Mol Biol. 1995;254:350–63.

    Article  CAS  PubMed  Google Scholar 

  • Garrett ED, Cullen BR. Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2. J Virol. 1992;66:4288–94.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Herschhorn A, Hizi A. Retroviral reverse transcriptases. Cell Mol Life Sci. 2010;67:2717–47.

    Article  CAS  PubMed  Google Scholar 

  • Kirchhoff F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe. 2010;8:55–67.

    Article  CAS  PubMed  Google Scholar 

  • Kjems J, Askjaer P. Rev protein and its cellular partners. Adv Pharmacol. 2000;48:251–98.

    Article  CAS  PubMed  Google Scholar 

  • L’Hernault A, Weiss EU, Greatorex JS, Lever AM. HIV-2 genome dimerization is required for the correct processing of gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses. J Virol. 2012;86:5867–76.

    Article  PubMed Central  PubMed  Google Scholar 

  • Le Tortorec A, Willey S, Neil SJ. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses. 2011;3:520–40.

    Article  PubMed Central  PubMed  Google Scholar 

  • Lever AM. HIV-1 RNA packaging. Adv Pharmacol. 2007;55:1–32.

    Article  CAS  PubMed  Google Scholar 

  • Marcello A, Zoppe M, Giacca M. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life. 2001;51:175–81.

    Article  CAS  PubMed  Google Scholar 

  • Roquebert B, Damond F, Collin G, Matheron S, Peytavin G, Benard A, et al. HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro. J Antimicrob Chemother. 2008;62:914–20.

    Article  CAS  PubMed  Google Scholar 

  • Tomasselli AG, Hui JO, Sawyer TK, Staples DJ, Bannow C, Reardon IM, et al. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J Biol Chem. 1990;265:14675–83.

    CAS  PubMed  Google Scholar 

  • Weiss ER, Gottlinger H. The role of cellular factors in promoting HIV budding. J Mol Biol. 2011;410:525–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Cambridge, Cambridge, UK

    Andrew M. L. Lever

Authors
  1. Andrew M. L. Lever
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew M. L. Lever .

Editor information

Editors and Affiliations

  1. Dept. Cell & Molecular Biology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA

    Thomas J. Hope

  2. Office of Graduate and Postdoctoral Studies, University of Miami, Miller School of Medicine, Miami, Florida, USA

    Mario Stevenson

  3. University of California, San Diego Dept. Pathology, La Jolla, California, USA

    Douglas Richman

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Lever, A.M.L. (2013). Molecular Biology of HIV-2. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_43-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_43-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation